Skip to main content

September 2024

Digital Edition

View the leading publication in corporate real estate, facility planning, location analysis and foreign direct investment right in your browser. Download the issue, share it on social media, or email to your colleagues all from your desktop.

Read September 2024 Issue

Cover Story

Canada’s Best Locations 2024

Based on corporate facility project investment data, Ontario secures the Canadian Competitiveness Award among provinces and 20 regions distinguish themselves as Canada’s Best Locations.

Read Cover Story

Features

Top Utilities 2024: Power Provision Is Just the Beginning

Based on corporate end-user facility investments in their territories, these are this year’s top utilities in economic development. An online-only bonus story features their direct answers to a big question from us and their customers: “Amid a glut of heavy-load industrial projects, how is your team working with operations and external stakeholders to address power provision?”

Top Utilities Provide Exclusive Insights Into the Pressing Need for More Power

Power provision is vying with workforce as the most pressing issue for industrial companies nationwide amid a glut of major industrial facility projects (data centers, semiconductor fabs, EV/battery supply chain, etc.). How is your utility’s economic development team working with operations and external stakeholders to address these concerns?

Investment Profiles

International

Qatar Has Space to Innovate

We explore the $45 billion Lusail City, new incentives for AI and tech in Saudi Arabia, and the massive Tasreef Project in Dubai.

Thailand’s Investment Hub

A new, nine-square-mile Capital City is being developed in Thailand’s Eastern Economic Corridor, which is at the forefront of the country’s foreign investment strategy.

Departments

Area Spotlights

Investment Reports

Intelligence Reports

Special Advertising Sections

Sanofi Bets Big in Europe

Investments in its home country and in Germany demonstrate French biopharma giant Sanofi’s commitment to European production.